x
Barcelona, null

Abstract by Chad Oh, Director, Clinical Development, J. Parker, G. Geba and N. Molfino on the safety profile and clinical activity of multiple subcutaneous (SC) doses of MEDI-528.

Abstract by David Gossage, Director, Clinical Development, J. Parker, G. Geba and N. Molfino titled Subcutaneous (SC) MEDI-563; Effect on blood IL-5, ECP, EDN, and eotaxin in adult asthmatics.

Abstract by Feng Jin, Scientist II, D.L. Gossage, W. White, etc. titled A multiple subcutaneous (SC) dose study of MEDI-563: a humanized anti-125RA monoclonal antibody in adult asthmatics.

Abstract by David Gossage, Director, Clinical Development, J. Parker, G. Geba and N. Molfino titled
Multiple ascending subcutaneous (SC) dose study of MEDI-563: pharmacokinetics and immune response in adult asthmatics.

Added by MedImmune on April 13, 2010

Interested 1